Amplia Therapeutics Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amplia Therapeutics Ltd with three other
companies in this sector in AUSTRALIA :
Vectus Biosystems Ltd
(2020
sales of 51,186.00 Australian Dollars [US$39,013.97 ]
),
Antisense Therapeutics Limited
(30,528.00 Australian Dollars [US$23,268.44 ]
), and
Race Oncology Ltd
(9,316.00 Australian Dollars [US$7,100.66 ]
).
Sales Analysis.
Amplia Therapeutics Ltd reported sales of A$34,227.00 (US$26.09 thousand)
for the
fiscal
year ending
March of 2020.
This
represents
a
sharp
decrease of 32.2%
versus 2019, when the company's sales were A$50,474.00 .